Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluzone Revaccination in Healthy Adults
NCT01011049Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2009
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of Fluzone Trivalent in influenza, sponsored by Sanofi. Started Sep 2009; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01011049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011049.